Source: International Congress 2016 – Prognostic variables in lung cancer II



Rating:

Share or cite this content

Citations should be made in the following way:
Tuncay Göksel (Izmir, Turkey), Levent Pelit, Tuncay Göksel, Tugberk Nail Dizdas, Ilknur Bagatir, Füsun Pelit, Özlem Göksel, Hasan Ertas, Hülya Samancioglu, Burak Ordin, Arif Gürsoy, Durmus Özdemir, Haydar S. Karakus, Münevver Erdinç, F. Nil Ertas. Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]). Eur Respir J 2016; 48: Suppl. 60, 2870

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Breath collection related factors may influence electronic nose ability to detect lung cancer Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Detection of early stage lung cancer by electronic nose Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Airway biomarkers Year: 2016 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Exhaled breath temperature in NSCLC: Could be a new non invasive marker? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Electronic nose as a screening tool for early stage lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 LATE-BREAKING ABSTRACT: New algorithm of lung cancer diagnosis by analysis of exhaled breath with electronic nose and multifactorial logistic regression method Source: International Congress 2014 – Thoracic tumours: news from the lab Year: 2014 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Evaluation of spirometry test as monitoring tool in lung cancer patients Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016